These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19246643)

  • 1. Oxidative stress-mediated mitochondrial dysfunction contributes to angiotensin II-induced nonalcoholic fatty liver disease in transgenic Ren2 rats.
    Wei Y; Clark SE; Thyfault JP; Uptergrove GM; Li W; Whaley-Connell AT; Ferrario CM; Sowers JR; Ibdah JA
    Am J Pathol; 2009 Apr; 174(4):1329-37. PubMed ID: 19246643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats.
    Wei Y; Clark SE; Morris EM; Thyfault JP; Uptergrove GM; Whaley-Connell AT; Ferrario CM; Sowers JR; Ibdah JA
    J Hepatol; 2008 Sep; 49(3):417-28. PubMed ID: 18486983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 rat.
    Whaley-Connell A; Govindarajan G; Habibi J; Hayden MR; Cooper SA; Wei Y; Ma L; Qazi M; Link D; Karuparthi PR; Stump C; Ferrario C; Sowers JR
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E355-63. PubMed ID: 17440033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression.
    Blendea MC; Jacobs D; Stump CS; McFarlane SI; Ogrin C; Bahtyiar G; Stas S; Kumar P; Sha Q; Ferrario CM; Sowers JR
    Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E353-9. PubMed ID: 15494608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NADPH oxidase contributes to vascular inflammation, insulin resistance, and remodeling in the transgenic (mRen2) rat.
    Wei Y; Whaley-Connell AT; Chen K; Habibi J; Uptergrove GM; Clark SE; Stump CS; Ferrario CM; Sowers JR
    Hypertension; 2007 Aug; 50(2):384-91. PubMed ID: 17533199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat.
    Whaley-Connell AT; Chowdhury NA; Hayden MR; Stump CS; Habibi J; Wiedmeyer CE; Gallagher PE; Tallant EA; Cooper SA; Link CD; Ferrario C; Sowers JR
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1308-14. PubMed ID: 16788142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomics in angiotensin II-induced cardiac hypertrophy.
    Mervaala E; Biala A; Merasto S; Lempiäinen J; Mattila I; Martonen E; Eriksson O; Louhelainen M; Finckenberg P; Kaheinen P; Muller DN; Luft FC; Lapatto R; Oresic M
    Hypertension; 2010 Feb; 55(2):508-15. PubMed ID: 20065148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress contributes to pulmonary hypertension in the transgenic (mRen2)27 rat.
    DeMarco VG; Habibi J; Whaley-Connell AT; Schneider RI; Heller RL; Bosanquet JP; Hayden MR; Delcour K; Cooper SA; Andresen BT; Sowers JR; Dellsperger KC
    Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2659-68. PubMed ID: 18424632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of direct renin inhibition with angiotensin type 1 receptor blockade improves aldosterone but does not improve kidney injury in the transgenic Ren2 rat.
    Whaley-Connell A; Habibi J; Nistala R; Hayden MR; Pulakat L; Sinak C; Locher B; Ferrario CM; Sowers JR
    Regul Pept; 2012 Jun; 176(1-3):36-44. PubMed ID: 22465166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of renin inhibition and AT1R blockade on myocardial remodeling in the transgenic Ren2 rat.
    Whaley-Connell A; Habibi J; Cooper SA; Demarco VG; Hayden MR; Stump CS; Link D; Ferrario CM; Sowers JR
    Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E103-9. PubMed ID: 18460596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of biphasic effect on Na/K-ATPase activity by angiotensin II involves defective angiotensin type 1 receptor-nitric oxide signaling.
    Banday AA; Lokhandwala MF
    Hypertension; 2008 Dec; 52(6):1099-105. PubMed ID: 18955661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salt loading exacerbates diastolic dysfunction and cardiac remodeling in young female Ren2 rats.
    Whaley-Connell AT; Habibi J; Aroor A; Ma L; Hayden MR; Ferrario CM; Demarco VG; Sowers JR
    Metabolism; 2013 Dec; 62(12):1761-71. PubMed ID: 24075738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proximal tubule microvilli remodeling and albuminuria in the Ren2 transgenic rat.
    Hayden MR; Chowdhury NA; Cooper SA; Whaley-Connell A; Habibi J; Witte L; Wiedmeyer C; Manrique CM; Lastra G; Ferrario C; Stump C; Sowers JR
    Am J Physiol Renal Physiol; 2007 Feb; 292(2):F861-7. PubMed ID: 17032939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative beneficial effects of nebivolol and nebivolol/valsartan combination against mitochondrial dysfunction in angiotensin II-induced pathology in H9c2 cardiomyoblasts.
    Gul R; Alsalman N; Bazighifan A; Alfadda AA
    J Pharm Pharmacol; 2021 Oct; 73(11):1520-1529. PubMed ID: 34453839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of angiotensin II and reactive oxygen species in cyclosporine A-dependent hypertension.
    Nishiyama A; Kobori H; Fukui T; Zhang GX; Yao L; Rahman M; Hitomi H; Kiyomoto H; Shokoji T; Kimura S; Kohno M; Abe Y
    Hypertension; 2003 Oct; 42(4):754-60. PubMed ID: 12874088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.
    Kohjima M; Enjoji M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Fujino T; Yada M; Yada R; Harada N; Takayanagi R; Nakamuta M
    Int J Mol Med; 2007 Sep; 20(3):351-8. PubMed ID: 17671740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat.
    Whaley-Connell A; Nistala R; Habibi J; Hayden MR; Schneider RI; Johnson MS; Tilmon R; Rehmer N; Ferrario CM; Sowers JR
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F655-61. PubMed ID: 20007350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension.
    Elmarakby AA; Williams JM; Imig JD; Pollock JS; Pollock DM
    Vascul Pharmacol; 2007 Feb; 46(2):144-51. PubMed ID: 17112788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of insulin-sensitizing agents in combination with ezetimibe, and valsartan in rats with non-alcoholic fatty liver disease.
    Assy N; Grozovski M; Bersudsky I; Szvalb S; Hussein O
    World J Gastroenterol; 2006 Jul; 12(27):4369-76. PubMed ID: 16865780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telmisartan but not valsartan increases caloric expenditure and protects against weight gain and hepatic steatosis.
    Sugimoto K; Qi NR; Kazdová L; Pravenec M; Ogihara T; Kurtz TW
    Hypertension; 2006 May; 47(5):1003-9. PubMed ID: 16567593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.